Logo

UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

Share this

UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

Shots:

  • The collaboration will merge Microsoft’s computational services- cloud and AI with UCB’s drug discovery and development capabilities
  • The companies intend to discover and develop medicines for people living with severe diseases in immunology and neurology. The collaboration follows UCB and Microsoft’s collaboration around COVID-19
  • Microsoft will provide AI technology and applied scientists to work alongside UCB's scientist and data specialist that will allow UCB to discover new correlations and patterns critical to find new and highly individualized medicines

 ­ Ref: PRNewswire | Image: PRNewswire

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions